From idea to ETF portfolio in minutes. Build yours now →
The proposal to reclassify cannabis to Schedule III sparks a 30% surge in cannabis funds as the Biden administration signals strong support for medical marijuana legalization.


Keep up with what matters in ETFs
Get timely ETF insights, market trends, and top ideas straight to your inbox.
Your newsletter subscriptions with us are subject to ETF Central's Privacy Policy and Terms and Conditions.
The recent proposal by the U.S. Department of Health and Human Services (HHS) to reclassify cannabis from Schedule I to Schedule III status under the Controlled Substances Act (CSA) saw cannabis funds enjoy a performance gain of +30% over the course of last week. Despite its continued classification as a substance with a high potential for abuse, this proposed reclassification indicates a growing acknowledgment of its lower risk in terms of physical and psychological dependence.
The Biden administration is firmly committed to advocating for the legalization of medical marijuana, a stance confirmed by the President's press secretary during a briefing last week. In response to questions about this matter, White House Press Secretary Karine Jean-Pierre said that “the President has always supported the legalization of marijuana for medical purposes – he’s been very clear about that – where appropriate, consistent with medical and scientific evidence.”
Investors in Cannabis ETFs are getting their hopes up very high on the news, finding it to be a refreshing change after experiencing recurring episodes of disappointing performance in their investments. ETFs centered on companies in the cannabis industry have witnessed substantial gains, with shares surging by double digits and averaging a weekly performance increase of +17.45%. Consequently, they have shifted into positive territory for their year-to-date returns, reaching +5.65%. Despite encountering initial setbacks at the beginning of 2023, the Cannabis & Psychedelics theme has orchestrated significant turnaround efforts, culminating in positive year-to-date results.
As an illustration, the AdvisorShares Pure US Cannabis ETF (MSOS) gained +23.16% over the week with inflows of more than $36 million and a year-to-date performance of +20.22%.
With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.


Please note this article is for information purposes only and does not in any way constitute investment advice. It is essential that you seek advice from a registered financial professional prior to making any investment decision.
Latest ETF News
See all ETF newsChart of the Day 11/18/26: Tech Keeps Glitching – But These Stocks Don't!


MoneyShow Chart of the Day 11/11/2026: Wall Street Just Panicked. Is That...GOOD?


MoneyShow Chart of the Day 11/6/2026: Now, That's What I Call a Fake Out!


SPONSORED ARTICLE
xETFs Lists SMNG, a Single-Ticker Samsung Group ETF for U.S. Investors


Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
First Look ETF
First Look ETF: Conventional and Unconventional International ETFs
First Look ETF’s November episode covers record-setting ETF launches and inflows with the NYSE, William Blair’s new active international and emerging markets ETFs, and the launch of the Long Nook Uncommon Compounders ETF (LUNC).

ETF Trends
ETF Industry KPIs November 16, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

ETF Trends
ETF Industry KPIs November 9, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

ETF Trends
ETF Industry KPIs November 3, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
